What is Marathon drug?

What is Marathon drug?

Marathon Pharmaceuticals Begins New Drug Application Process for Deflazacort to Treat Duchenne Muscular Dystrophy. Deflazacort, a corticosteroid, works as an anti-inflammatory and immunosuppressant.

Is Deflazacort available in USA?

Corticosteroids are commonly used to treat DMD across the world. This is the first FDA approval of any corticosteroid to treat DMD and the first approval of deflazacort for any use in the United States.

Who owns Marathonmaps?

Marathon Pharmaceuticals

How does Deflazacort help DMD?

Once metabolized to its active form, Emflaza acts to suppress the immune system. The precise mechanism by which Emflaza slows the progression of DMD is unclear, but its effect is thought to be mediated by the suppression of the immune system, thereby reducing muscle damage.

Do they drug test for the Boston Marathon?

Athletes competing in the Event are subject to blood and/or urine testing for any substance or method on the World Anti-Doping Agency (“WADA”) Prohibited List: www.usada.org/prohibited-list/.

Is deflazacort and prednisolone same?

Deflazacort is a glucocorticoid derived from prednisolone and 6 mg of deflazacort it has approximately the same anti-inflammatory potency as 5 mg prednisolone or prednisone. Doses vary widely in different diseases and different patients.

Where can I get deflazacort?

Deflazacort will be made available from Marathon’s U.S. Patient Support Services team. It will not be available at your local pharmacy.

Is deflazacort safe?

People who use deflazacort for a long time may develop glaucoma or cataracts. Talk to your doctor about the risks of using deflazacort and how often you should have your eyes examined during your treatment. Deflazacort may increase your risk of developing osteoporosis.

Do Marathon runners take PEDs?

Use of PEDs in ultra-marathons: A growing number of ultra-marathons now have drug tests for the use of performance enhancing drugs (PEDs) in response to increased competition and rewards becoming more lucrative. The Western States 100 introduced doping tests a few years ago to ensure the integrity of the race.

How much does deflazacort cost?

Monday, deflazacort got a new price tag: $35,000 a year for a patient in the U.S. weighing 25 kilograms, or about 55 pounds. To McSherry, the $35,000 is “pretty aggressive.” What’s worse, in her eyes, is that most kids who may take the drug weigh more than 25 kilograms, meaning the price will be even higher.

What is the price of deflazacort?

Questions & Answers on Deflazacort Tablets

What kind of diseases does Marathon Pharmaceuticals treat?

Marathon developed medications that targeted neurological, muscular, gastrointestinal and blood disorders, including deflazacort, a new medication to slow the progression of Duchenne muscular dystrophy (DMD) in patients. In January 2015, Marathon was granted fast track status from FDA for deflazacort as a potential treatment for DMD.

Who is the CEO of Marathon pharmaceutical company?

Deflazacort. On February 13, 2017, the CEO of Marathon, Jeff Aronin, announced that after four years of development and over 17 trials, the company was granted FDA approval for deflazacort (Emflaza) to treat Duchenne muscular dystrophy, a rare disease that affects approximately 15,000 young boys in the U.S.

How does Emflaza work to treat muscular dystrophy?

Emflaza is a corticosteroid that works by decreasing inflammation and reducing the activity of the immune system. Corticosteroids are commonly used to treat DMD across the world.